REFERENCES
1. Cronin KA, Lake AJ, Scott S, et al. Annual report to the nation on the status of cancer, part I: national cancer statistics. Cancer 2018;124:2785-2800.
3. Siegel RL, Miller KD, Jemal A. Colorectal cancer mortality rates in adults aged 20 to 54 years in the United States, 1970-2014. JAMA 2017;318:572-4.
4. Steele G Jr, Ravikumar TS. Resection of hepatic metastases from colorectal cancer. Biologic perspective. Ann Surg 1989;210:127-38.
5. Blumgart LH, Allison DJ. Resection and embolization in the management of secondary hepatic tumors. World J Surg 1982;6:32-45.
6. Riihimäki M, Hemminki A, Sundquist J, Hemminki K. Patterns of metastasis in colon and rectal cancer. Sci Rep 2016;6:29765.
7. Lafortune M, Denys A, Sauvanet A, Schmidt S. Anatomy of the liver: what you need to know. J Radiol 2007;88:1020-35.
8. Brandi G, Ricci AD, Rizzo A, et al. Is post-transplant chemotherapy feasible in liver transplantation for colorectal cancer liver metastases? Cancer Commun 2020;40:461-4.
9. Soon DSC, Chae MP, Pilgrim CHC, Rozen WM, Spychal RT, Hunter-Smith DJ. 3D haptic modelling for preoperative planning of hepatic resection: a systematic review. Ann Med Surg 2016;10:1-7.
10. Ballard DH, Wake N, Witowski J, Rybicki FJ, Sheikh A. RSNA Special Interest Group for 3D Printing Abdominal; Hepatobiliary; and Gastrointestinal Conditions Voting Group. Radiological Society of North America (RSNA) 3D Printing Special Interest Group (SIG) clinical situations for which 3D printing is considered an appropriate representation or extension of data contained in a medical imaging examination: abdominal, hepatobiliary, and gastrointestinal conditions. 3D Print Med 2020;6:13.
11. Wang JZ, Xiong NY, Zhao LZ, Hu JT, Kong DC, Yuan JY. Review fantastic medical implications of 3D-printing in liver surgeries, liver regeneration, liver transplantation and drug hepatotoxicity testing: a review. Int J Surg 2018;56:1-6.
12. Moris D, Ronnekleiv-Kelly S, Rahnemai-Azar AA, et al. Parenchymal-sparing versus anatomic liver resection for colorectal liver metastases: a systematic review. J Gastrointest Surg 2017;21:1076-85.
13. FDA. Indications for Use - syngo.CT liver analysis. Available from: https://www.accessdata.fda.gov/cdrh_docs/pdf13/K133643.pdf. [Last accessed on 28 Oct 2024].
14. Igami T, Nakamura Y, Hirose T, et al. Application of a three-dimensional print of a liver in hepatectomy for small tumors invisible by intraoperative ultrasonography: preliminary experience. World J Surg 2014;38:3163-6.
15. Mise Y, Aloia TA, Brudvik KW, Schwarz L, Vauthey JN, Conrad C. Parenchymal-sparing hepatectomy in colorectal liver metastasis improves salvageability and survival. Ann Surg 2016;263:146-52.
16. Fretland ÅA, Dagenborg VJ, Bjørnelv GMW, et al. Laparoscopic versus open resection for colorectal liver metastases: the OSLO-COMET randomized controlled trial. Ann Surg 2018;267:199-207.
17. Barimani D, Kauppila JH, Sturesson C, Sparrelid E. Imaging in disappearing colorectal liver metastases and their accuracy: a systematic review. World J Surg Oncol 2020;18:264.
